C118H142Cl4N24O11 — CID 161166328
3-[6-[(3R)-3-(2-aminoethylamino)cyclohexyl]-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one;tert-butyl 4-[2-[4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperidine-1-carboxylate;tert-butyl 4-[2-[4-[2-(4-chloropyrazol-1-yl)ethylamino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperidine-1-carboxylate;4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[1-[2-(dimethylamino)ethyl]piperidin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one (PubChem CID 161166328) has the molecular formula C118H142Cl4N24O11 and a molecular weight of 2214.40 g/mol. Its IUPAC name is 3-[6-[(3R)-3-(2-aminoethylamino)cyclohexyl]-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one;tert-butyl 4-[2-[4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperidine-1-carboxylate;tert-butyl 4-[2-[4-[2-(4-chloropyrazol-1-yl)ethylamino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperidine-1-carboxylate;4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[1-[2-(dimethylamino)ethyl]piperidin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one.
| Compound Name | 3-[6-[(3R)-3-(2-aminoethylamino)cyclohexyl]-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one;tert-butyl 4-[2-[4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperidine-1-carboxylate;tert-butyl 4-[2-[4-[2-(4-chloropyrazol-1-yl)ethylamino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperidine-1-carboxylate;4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[1-[2-(dimethylamino)ethyl]piperidin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one |
|---|---|
| PubChem CID | 161166328 |
| Molecular Formula | C118H142Cl4N24O11 |
| Molecular Weight | 2214.40 g/mol |
| Exact Mass | 2211.00 |
| IUPAC Name | 3-[6-[(3R)-3-(2-aminoethylamino)cyclohexyl]-4-methyl-1H-benzimidazol-2-yl]-4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-1H-pyridin-2-one;tert-butyl 4-[2-[4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperidine-1-carboxylate;tert-butyl 4-[2-[4-[2-(4-chloropyrazol-1-yl)ethylamino]-2-oxo-1H-pyridin-3-yl]-7-methyl-3H-benzimidazol-5-yl]piperidine-1-carboxylate;4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[6-[1-[2-(dimethylamino)ethyl]piperidin-4-yl]-4-methyl-1H-benzimidazol-2-yl]-1H-pyridin-2-one |
| SMILES | Cc1cc(C2CCC[C@@H](NCCN)C2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12.Cc1cc(C2CCN(C(=O)OC(C)(C)C)CC2)cc2[nH]c(-c3c(NCCn4cc(Cl)cn4)cc[nH]c3=O)nc12.Cc1cc(C2CCN(C(=O)OC(C)(C)C)CC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12.Cc1cc(C2CCN(CCN(C)C)CC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12 |
| InChI | InChI=1S/C31H36ClN5O4.C30H37ClN6O2.C29H35ClN6O2.C28H34ClN7O3/c1-18-14-21(19-9-12-37(13-10-19)30(40)41-31(2,3)4)16-24-27(18)36-28(35-24)26-23(8-11-33-29(26)39)34-17-25(38)20-6-5-7-22(32)15-20;1-19-15-22(20-8-11-37(12-9-20)14-13-36(2)3)17-25-28(19)35-29(34-25)27-24(7-10-32-30(27)39)33-18-26(38)21-5-4-6-23(31)16-21;1-17-12-20(18-4-3-7-22(14-18)32-11-9-31)15-24-27(17)36-28(35-24)26-23(8-10-33-29(26)38)34-16-25(37)19-5-2-6-21(30)13-19;1-17-13-19(18-6-10-35(11-7-18)27(38)39-28(2,3)4)14-22-24(17)34-25(33-22)23-21(5-8-31-26(23)37)30-9-12-36-16-20(29)15-32-36/h5-8,11,14-16,19,25,38H,9-10,12-13,17H2,1-4H3,(H,35,36)(H2,33,34,39);4-7,10,15-17,20,26,38H,8-9,11-14,18H2,1-3H3,(H,34,35)(H2,32,33,39);2,5-6,8,10,12-13,15,18,22,25,32,37H,3-4,7,9,11,14,16,31H2,1H3,(H,35,36)(H2,33,34,38);5,8,13-16,18H,6-7,9-12H2,1-4H3,(H,33,34)(H2,30,31,37)/t25-;26-;18?,22-,25-;/m111./s1 |
| InChIKey | UQOWXKDIADWILT-QRPYXCERSA-N |
| XLogP | 20.81 |
| TPSA | 476.40 Ų |
| H-Bond Donors | 17 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 157 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2214.40 |
| LogP ≤ 5 | 20.81 |
| H-Bond Donors ≤ 5 | 17 |
| H-Bond Acceptors ≤ 10 | 25 |